PHVs are viruses of human origin that lived in the era of the viral world and were able to fight and defeat other viruses without being eradicated. The world continued its transformation and caused these viruses to turn into cells, tissues, organs, systems as well as humans. Medicines derived from these viruses have the ability to kill all types of viruses that can affect humans and return the body to its normal state without causing any harm.
MECHANISM OF PLASMATIC HUMAN VIRUS (PHV) IN HUMAN BODY
The Plasmatic Human Virus (PHV) is the DNA virus in origin, when introduce in human body through blood capillaries interface with retro virus (abnormal m-RNA). The retro virus normally its effectiveness depend on aid from reverse transcriptase enzymes in cytoplasm, where Plasmatic Human Virus (PHV) form only nuclear without cytoplasm, so during interfaces of these nucleotide there deficiency state where end with formations of negative radioactive nitrogen which cause the patient to have dry cough, oxygen gas which cause small rash with itch on skin of patient which is transient, normal m-RNA of PHV and DNA of PHV.
During first exposure of HIV patient on Plasmatic Human Virus (PHV), the Cd 4 elevate as 100 cubic milliters/dl per month on two to three months then drops to lower levels depend on the retro virus DNA load. Then after finish all retro virus DNA and RNA, the level Plasmatic Human Virus (PHV) decrease and Cd 4 rise up again to normal level.
The Plasmatic Human Virus (PHV), its Acetylene CH2C at nuclear fission point change to exactly contents of gastric juice where cause excessively excretion of bile content to duodenum.
The Plasmatic Human Virus (PHV) on the way of nuclear fission produce chemical elements by bolus mechanism with Hydroxyl Enzymes where act together in nuclear as the factor of cell differentiation. The cell differentiation carried by Plasmatic Human Virus (PHV) encounter any defects bring with HIV strains, so by that it repair all cells of the human body,
The plasmatic human virus (PHV) constructed in targeted environments as the human body in general divided in three main parts as follows;
1. Intestine-The place where crude oil refine.
2. Blood-The place where refined fuel stored.
3. Cells- Engine.
The HIV strains destroys human engine (cells) where use it as the law material for multiplication process. The number of human cells(engine) reduce to minimal critical level where the human die. As the number of HIV strains increase the gastrointestinal truck upset arise.
The plasmatic human virus (PHV) created from small amount of stored material in the blood, as there create deficit which as the factor of hungry desire in the stomach. The stored material serve for fuel human cells and yield of plasmatic human virus (PHV).
Recto-virus in hence multiplication inside human cells, and its DNA lodge inside the human cells, so multiplication of it depend on its DNA order and law material from cytoplasm of the cells, while PHV is the DNA and create some thing like nuclear out side the human cells (at interstitial fluids). The recto-virus invade PHV (DNA) by order of PHV where create m-RNA of PHV and DNA of HIV strains out side of cells. The m-RNA of PHV invade the human cells by order of DNA of HIV strains where produce PHV (DNA) inside the human cells and recto-virus out side the cells. in shortly all recto virus DNA lodge out side the human cells where destroyed as negative radioactive Nitrogen, and Oxygen.
W.H.O CLINICAL STAGES
Home / Guide for HIV/AIDS Clinical Care / Section 2: Testing and Assessment
HIV Classification: CDC and WHO Staging Systems
Background
HIV disease staging and classification systems are critical tools for tracking and monitoring the HIV epidemic and for providing clinicians and patients with important information about HIV disease stage and clinical management. Two major classification systems currently are in use: the U.S. Centers for Disease Control and Prevention (CDC) classification system and the World Health Organization (WHO) Clinical Staging and Disease Classification System.
The CDC disease staging system (most recently revised in 1993) assesses the severity of HIV disease by CD4 cell counts and by the presence of specific HIV-related conditions. The definition of AIDS includes all HIV-infected individuals with CD4 counts of <200 cells/µL (or CD4 percentage <14%) as well as those with certain HIV-related conditions and symptoms. Although the fine points of the classification system rarely are used in the routine clinical management of HIV-infected patients, a working knowledge of the staging criteria (in particular, the definition of AIDS) is useful in patient care. In addition, the CDC system is used in clinical and epidemiologic research.
In contrast to the CDC system, the WHO Clinical Staging and Disease Classification System (revised in 2007) can be used readily in resource-constrained settings without access to CD4 cell count measurements or other diagnostic and laboratory testing methods. The WHO system classifies HIV disease on the basis of clinical manifestations that can be recognized and treated by clinicians in diverse settings, including resource-constrained settings, and by clinicians with varying levels of HIV expertise and training.
S: Subjective
When a patient presents with a diagnosis of HIV infection, review the patient's history to elicit and document any HIV-related illnesses or symptoms (see chapter Initial History).
O: Objective
Perform a complete physical examination and appropriate laboratory studies (see chapters Initial Physical Examination and Initial and Interim Laboratory and Other Tests).
A: Assessment
Confirm HIV infection and perform staging.
P: Plan
Evaluate symptoms, history, physical examination results, and laboratory results, and make a staging classification according to the CDC or WHO criteria (see below).
CDC Classification System for HIV Infection
The CDC categorization of HIV/AIDS is based on the lowest documented CD4 cell count and on previously diagnosed HIV-related conditions (see Table 1). For example, if a patient had a condition that once met the criteria for category B but now is asymptomatic, the patient would remain in category B. Additionally, categorization is based on specific conditions, as indicated below. Patients in categories A3, B3, and C1-C3 are considered to have AIDS.
| CD4 Cell Count Categories | Clinical Categories | ||
|---|---|---|---|
| A Asymptomatic, Acute HIV, or PGL | B* Symptomatic Conditions, not A or C | C# AIDS-Indicator Conditions | |
Abbreviations: PGL = persistent generalized lymphadenopathy
| |||
| (1) ≥500 cells/µL | A1 | B1 | C1 |
| (2) 200-499 cells/µL | A2 | B2 | C2 |
| (3) <200 cells/µL | A3 | B3 | C3 |
* Category B Symptomatic Conditions
Category B symptomatic conditions are defined as symptomatic conditions occurring in an HIV-infected adolescent or adult that meet at least one of the following criteria:
- They are attributed to HIV infection or indicate a defect in cell-mediated immunity.
- They are considered to have a clinical course or management that is complicated by HIV infection.
Examples include, but are not limited to, the following:
- Bacillary angiomatosis
- Oropharyngeal candidiasis (thrush)
- Vulvovaginal candidiasis, persistent or resistant
- Pelvic inflammatory disease (PID)
- Cervical dysplasia (moderate or severe)/cervical carcinoma in situ
- Hairy leukoplakia, oral
- Herpes zoster (shingles), involving two or more episodes or at least one dermatome
- Idiopathic thrombocytopenic purpura
- Constitutional symptoms, such as fever (>38.5°C) or diarrhea lasting >1 month
- Peripheral neuropathy
# Category C AIDS-Indicator Conditions
- Bacterial pneumonia, recurrent (two or more episodes in 12 months)
- Candidiasis of the bronchi, trachea, or lungs
- Candidiasis, esophageal
- Cervical carcinoma, invasive, confirmed by biopsy
- Coccidioidomycosis, disseminated or extrapulmonary
- Cryptococcosis, extrapulmonary
- Cryptosporidiosis, chronic intestinal (>1 month in duration)
- Cytomegalovirus disease (other than liver, spleen, or nodes)
- Encephalopathy, HIV-related
- Herpes simplex: chronic ulcers (>1 month in duration), or bronchitis, pneumonitis, or esophagitis
- Histoplasmosis, disseminated or extrapulmonary
- Isosporiasis, chronic intestinal (>1-month in duration)
- Kaposi sarcoma
- Lymphoma, Burkitt, immunoblastic, or primary central nervous system
- Mycobacterium avium complex (MAC) or Mycobacterium kansasii, disseminated or extrapulmonary
- Mycobacterium tuberculosis, pulmonary or extrapulmonary
- Mycobacterium, other species or unidentified species, disseminated or extrapulmonary
- Pneumocystis jiroveci (formerly carinii) pneumonia (PCP)
- Progressive multifocal leukoencephalopathy (PML)
- Salmonella septicemia, recurrent (nontyphoid)
- Toxoplasmosis of brain
- Wasting syndrome caused by HIV (involuntary weight loss >10% of baseline body weight) associated with either chronic diarrhea (two or more loose stools per day for ≥1 month) or chronic weakness and documented fever for ≥1 month
WHO Clinical Staging of HIV/AIDS and Case Definition
The clinical staging and case definition of HIV for resource-constrained settings were developed by the WHO in 1990 and revised in 2007. Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS, and it does not require a CD4 cell count. This staging system is used in many countries to determine eligibility for antiretroviral therapy, particularly in settings in which CD4 testing is not available. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS (see Table 2). These stages are defined by specific clinical conditions or symptoms. For the purpose of the WHO staging system, adolescents and adults are defined as individuals aged ≥15 years.
| Clinical Stage | Clinical Conditions or Symptoms |
|---|---|
| Primary HIV Infection |
|
| Clinical Stage 1 |
|
| Clinical Stage 2 |
|
| Clinical Stage 3 |
|
| Clinical Stage 4 |
|
These are drugs which reduce side effects of HIV strains break down, where release some chemical elements which may not harm the patient's body.
Trimosulfa or Cotrimozole is useful drug which can be administrate together with PHV vaccine. Inspite of its broad spectrum against opportunistic infections on AIDS such as Pneumocyst pneumonia, Isosporiasis (Isospora belli), at its end product bring by body metabolism with that of PHV end products form isocyanate R-N=C=O which react with hydrogen ions to form Formaldehyde and then formic acid and terminate to water and carbon dioxide. So reduce cough and small boil on skin of one use PHV vaccine. The uses of it together with PHV reduced due to presence of mega-plastic anemia where it advisable to use in short period as not more 7 days then folate take place where it have the same end metabolic out come with no side effect.
The chemical formula of folate comprises short organic formula which on body metabolism didn't affect liver than that of Cotrimazole.
The use of the folate should be controlled by elevation of haemoglobin blood levels as when it comes to normal level, the folate should stop, and if it found patient have low haemoglobin blood levels should start use again, these are normal intake because folate regulated by brain and when in excess will used by infectious bacteria in the body. So at normal level intake it strongly body immune systems and when in excess can favor multiplication of infectious bacteria in the body.
DRUGS AND FOODS WHICH AT OTHER HAND CAN HARM THE BODY OF VICTIM WHEN USE WITH PLASMATIC HUMAN VIRUS (PHV)
Penicillin group drugs after body metabolism end up with chemical element, which favor HIV multiplications.
Fungi foods should be avoided on period of time, as it's body metabolism end up with chemical element, which also favor HIV multiplications.
Trimosulfa or Cotrimozole is useful drug which can be administrate together with PHV vaccine. Inspite of its broad spectrum against opportunistic infections on AIDS such as Pneumocyst pneumonia, Isosporiasis (Isospora belli), at its end product bring by body metabolism with that of PHV end products form isocyanate R-N=C=O which react with hydrogen ions to form Formaldehyde and then formic acid and terminate to water and carbon dioxide. So reduce cough and small boil on skin of one use PHV vaccine. The uses of it together with PHV reduced due to presence of mega-plastic anemia where it advisable to use in short period as not more 7 days then folate take place where it have the same end metabolic out come with no side effect.
The chemical formula of folate comprises short organic formula which on body metabolism didn't affect liver than that of Cotrimazole.
The use of the folate should be controlled by elevation of haemoglobin blood levels as when it comes to normal level, the folate should stop, and if it found patient have low haemoglobin blood levels should start use again, these are normal intake because folate regulated by brain and when in excess will used by infectious bacteria in the body. So at normal level intake it strongly body immune systems and when in excess can favor multiplication of infectious bacteria in the body.
DRUGS AND FOODS WHICH AT OTHER HAND CAN HARM THE BODY OF VICTIM WHEN USE WITH PLASMATIC HUMAN VIRUS (PHV)
Penicillin group drugs after body metabolism end up with chemical element, which favor HIV multiplications.
Fungi foods should be avoided on period of time, as it's body metabolism end up with chemical element, which also favor HIV multiplications.
No comments:
Post a Comment